Overview
Samir Kanani is a Radiation Oncologist in Baltimore, Maryland. Dr. Kanani is rated as an Experienced provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor. Dr. Kanani is currently accepting new patients.
His clinical research consists of co-authoring 8 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22 S Green St, Baltimore, MD 21201
850 W Baltimore St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Kevin Camphausen is a Radiation Oncologist in Bethesda, Maryland. Dr. Camphausen is rated as a Distinguished provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
Radiation Oncology Associates PC
Kevin Choe is a Radiation Oncologist in Woodbridge, Virginia. Dr. Choe is rated as a Distinguished provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor. Dr. Choe is currently accepting new patients.
Khaled Aziz is a Radiation Oncologist in Baltimore, Maryland. Dr. Aziz is rated as an Experienced provider by MediFind in the treatment of Hemangioblastoma. His top areas of expertise are Prostate Cancer, Lung Cancer, Hemangioblastoma, and Non-Small Cell Lung Cancer (NSCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adenoid Cystic CarcinomaDr. Kanani isDistinguished. Learn about Adenoid Cystic Carcinoma.
- AstrocytomaDr. Kanani isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Kanani isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Kanani isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Kanani isDistinguished. Learn about Ependymoma.
- Familial Prostate CancerDr. Kanani isDistinguished. Learn about Familial Prostate Cancer.
- Advanced
- Anal CancerDr. Kanani isAdvanced. Learn about Anal Cancer.
- Brain TumorDr. Kanani isAdvanced. Learn about Brain Tumor.
- Breast CancerDr. Kanani isAdvanced. Learn about Breast Cancer.
- GliomaDr. Kanani isAdvanced. Learn about Glioma.
- HER-2 Positive Breast CancerDr. Kanani isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Lung CancerDr. Kanani isAdvanced. Learn about Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acoustic NeuromaDr. Kanani isExperienced. Learn about Acoustic Neuroma.
- Adult Soft Tissue SarcomaDr. Kanani isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Kanani isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Kanani isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Kanani isExperienced. Learn about Angiosarcoma.